Tectonic Therapeutic, Inc. (TECX) Investor Relations Documents

Tectonic Therapeutic, Inc. (TECX) investor relations documents from the company's IR site: 9 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-06	Press release	Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
2026-06-10	Press release	Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
2026-05-07	Press release	Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
2026-04-23	Press release	Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
2026-03-02	Press release	Tectonic Therapeutic to Participate in March Investor Conferences
2026-02-26	Press release	Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2026-02-23	Press release	Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
2026-02-11	Press release	Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditar
	Press release	Read More

TECX overview · TECX earnings · TECX financials · TECX KPIs · TECX ownership · TECX peers · TECX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.